Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391547 · ClinicalTrials.gov registry record · Phase 2
Pilot Efficacy Study to Treat Gingivitis
A Phase 2 study of Gingival Diseases, sponsored by Biomedical Development Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00391547: Completed Phase 2 study of Gingival Diseases, sponsored by Biomedical Development Corporation.
NCT00391547 is a Phase 2 study of Gingival Diseases that has completed, run by Biomedical Development Corporation. The registered enrollment target is 14 participants, below the 74-participant average among 4 other Gingival Diseases trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00391547, a Phase 2 study of Gingival Diseases, has completed, sponsored by Biomedical Development Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose is to demonstrate the efficacy of a prescription mouthrinse in human subjects for treatment of Gingivitis.
Conditions Studied
Interventions
- DRUG Frio Oral Rinse
Study Locations (1)
Missouri
- University of Missouri at Kansas City, School of Dentistry - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-01 |
| Phase | Phase 2 |
What the finished NCT00391547 record still lists
NCT00391547 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 74-participant average among 4 other Gingival Diseases trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Gingival Diseases appearing as the primary indexed condition, and to 1 intervention - of which Frio Oral Rinse is the first listed.
NCT00391547 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00391547 about?
NCT00391547 is a clinical study titled "Pilot Efficacy Study to Treat Gingivitis". The primary purpose is to demonstrate the efficacy of a prescription mouthrinse in human subjects for treatment of Gingivitis.
What is the current status of trial NCT00391547?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2006-10. Estimated completion is 2007-01.
What conditions does trial NCT00391547 study?
This clinical trial studies the following conditions: Gingival Diseases.
What interventions are being tested in trial NCT00391547?
The interventions under investigation include: Frio Oral Rinse (DRUG).
Who is sponsoring clinical trial NCT00391547?
This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00391547 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
OCT Vibrography for Biomechanical Properties of Tissues
RECRUITING · NA
-
Brief Title: a Clinical Study to Assess Gingivitis
COMPLETED · NA
-
Effect of Using Placental Membranes on Healing and Post-op Pain After Gum Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia